Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

WuXi Advanced Therapies

Year Established:
2018
Website:
advancedtherapies.com
Headquarters:
Philadelphia, PA, US
Company Type:
Large Business (>100M TTM Revenue)
Certifications:
  • Biosafety Level 2 (BSL 2)
  • Good Laboratory Practice (GLP) (unconfirmed)
  • International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use  (ICH)
  • International Safe Transit Association  (ISTA)
  • Justice of the Peace (JP)
  • Therapeutic Goods Administration (Australia) (TGA)

Wuxi Advanced Therapies: Contract Manufacturing & Development and Laboratory Testing Services for Cell, Gene, Protein and Viral-Based Therapeutics.

The Advanced Therapies unit of WuXi AppTec provides Fully-Integrated Services for Global Therapeutics. We leverage combined expertise in process development, cGMP manufacturing, testing and lot release platforms to drive development and commercialization. We help you get cell, gene, protein and viral-based therapies to market faster, and with greater predictability. Incorporating these offerings into a unified solution, WuXi Advanced Therapies can reduce project timelines, expedite first-in-human trials, and support commercial programs globally.

Our comprehensive CDMO services span the full range, from process development to final cGMP product manufacture. Along the way, we provide assay development, characterization, regulatory guidance, validation support and quality control testing for both processes and products. Whether large, mid-sized, small or virtual, pharmaceutical companies look to WuXi Advanced Therapies to help them develop a wide variety of Biotherapeutics, in both clinical and commercial settings.

We have decreased the complexities of high-touch, multi-vendor biopharmaceutical production by solving common, industry-wide constraints, such as:
• Security of Clinical and Commercial Supply
• Improvement of Immature Processes
• Challenges with Analytical Assays
• Personnel Shortages
• Capacity Constraints

As a provider of regulatory- and ISO-compliant contract testing and cGMP manufacturing services, The Advanced Therapies unit of WuXi AppTec possesses the full set of competencies, facilities, and key personnel to help clients take their products efficiently and cost effectively through the product development process and beyond.

Multiple, state-of-the-art facilities dedicate extensive square footage to development and cGMP manufacture of advanced gene and cell therapies (autologous & allogeneic). Likewise, considerable space is allocated to QC testing, including analytical, cell biology, molecular and virology.

Site Badges
WuXi Advanced Therapies
4751 League Island Boulevard Philadelphia, PA, 19112 United States
WuXi Advanced Therapies
4751 League Island Blvd Philadelphia, PA, 19112 United States
WuXi Advanced Therapies
4000 South 26th Street Philadelphia, PA, 19112 United States

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service